German chemical and pharmaceutical concern Bayer in the first quarter reduced its net profit by 6.2% in annual terms to 1 billion 950 million euros. Analysts had expected profits at the level of 1 billion 530 million euros. The decrease is due to the negative impact of changes in exchange rates. Quarterly revenues amounted to 9 billion 140 million euros, 31% down. The forecast of the analysts had assumed revenue at the level of 9 billion 300 million euros. The Pharmaceuticals division increased quarterly sales by 2.9% to €4 billion 75 million. At the same time, the unit's EBITDA decreased by 5.8% to 1 billion 415 million euros. Revenue in the department of the non-prescription medicinal products decreased by 2.2%. In the department of veterinary drugs, the indicator grew by 3%. In the agricultural business, revenue did not change much.
On Friday, the Chinese technology company ByteDance said that it would consider listing its domestic businesses in Hong Kong or Shanghai due to rising Sino-U.S. tensions. The company's standalone listing in Hong Kong or Shanghai might value ...
On Friday, Caterpillar Inc (CAT.N) announced a lower second-quarter profit because of the recession caused by the coronavirus outbreak. The decline was due to lower sales volume and changes in dealer inventories. During the second quarter ...
On Thursday, the United States’ Gross Domestic Product (GDP) suffered the biggest economic decline in the second quarter as the surge of coronavirus cases affected the whole country. The U.S. government decided to shut down restaurants, ...
Samsung Electronics Co Ltd looks forward to the second half of the year as it expects a larger increase in chip demand brought by new smartphone launches. However, the company warned that the coronavirus crisis and trade disputes carry risks. Samsung, ...
The second quarter had seen Australian consumer prices dropping by a record. This could be attributed to the coronavirus crisis dragging child care cost and petroleum prices, inflicting a serious damage to years of growth toward higher inflation. Last ...